Oct 24: Servier on Tuesday won its fifth FDA approval for Tibsovo (ivosidenib tablets)which also happens to be the first and only targeted therapy for patients with relapsed or refractory (R/R) myelodysplastic syndromes (MDS) with a susceptible IDH1 mutation
Who Contracts Lupus
Technical Beetroot Pro *Technical citations and PubMed references are provided for performance education only
Frequently Asked Questions (FAQ) Is AOD 9604 a steroid
A meta-analysis of randomized controlled trials found they can improve tendon structure, strength, and post-exercise recovery when combined with resistance training, though the quality of evidence remains moderate. Innovation is exciting, but recommending injectable, unregulated peptides to patients, without clinical validation should give us pause
Visceral fat exhibits higher metabolic activity, greater innervation, richer blood supply, and importantly, higher concentrations of beta-3 adrenergic receptors compared to most subcutaneous depots